NM_001134363.3:c.1807G>A

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BS1BS2

The NM_001134363.3(RBM20):​c.1807G>A​(p.Gly603Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000677 in 1,551,230 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G603G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00027 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000046 ( 0 hom. )

Consequence

RBM20
NM_001134363.3 missense

Scores

9
6
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 8.70

Publications

3 publications found
Variant links:
Genes affected
RBM20 (HGNC:27424): (RNA binding motif protein 20) This gene encodes a protein that binds RNA and regulates splicing. Mutations in this gene have been associated with familial dilated cardiomyopathy. [provided by RefSeq, Apr 2014]
RBM20 Gene-Disease associations (from GenCC):
  • dilated cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • dilated cardiomyopathy 1DD
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP6
Variant 10-110810389-G-A is Benign according to our data. Variant chr10-110810389-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 263763.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000269 (41/152284) while in subpopulation AMR AF = 0.00163 (25/15296). AF 95% confidence interval is 0.00114. There are 0 homozygotes in GnomAd4. There are 24 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 41 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RBM20NM_001134363.3 linkc.1807G>A p.Gly603Arg missense_variant Exon 8 of 14 ENST00000369519.4 NP_001127835.2 Q5T481
RBM20XM_017016103.3 linkc.1642G>A p.Gly548Arg missense_variant Exon 8 of 14 XP_016871592.1
RBM20XM_017016104.3 linkc.1423G>A p.Gly475Arg missense_variant Exon 8 of 14 XP_016871593.1
RBM20XM_047425116.1 linkc.1423G>A p.Gly475Arg missense_variant Exon 8 of 14 XP_047281072.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RBM20ENST00000369519.4 linkc.1807G>A p.Gly603Arg missense_variant Exon 8 of 14 1 NM_001134363.3 ENSP00000358532.3 Q5T481
RBM20ENST00000718239.1 linkc.1807G>A p.Gly603Arg missense_variant Exon 8 of 14 ENSP00000520684.1

Frequencies

GnomAD3 genomes
AF:
0.000269
AC:
41
AN:
152166
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000966
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00164
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00115
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000172
AC:
27
AN:
156524
AF XY:
0.000205
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000567
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000734
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000496
Gnomad OTH exome
AF:
0.000228
GnomAD4 exome
AF:
0.0000457
AC:
64
AN:
1398946
Hom.:
0
Cov.:
30
AF XY:
0.0000594
AC XY:
41
AN XY:
689994
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31596
American (AMR)
AF:
0.000476
AC:
17
AN:
35692
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25178
East Asian (EAS)
AF:
0.000336
AC:
12
AN:
35722
South Asian (SAS)
AF:
0.0000757
AC:
6
AN:
79210
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49244
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5696
European-Non Finnish (NFE)
AF:
0.0000260
AC:
28
AN:
1078624
Other (OTH)
AF:
0.0000172
AC:
1
AN:
57984
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000269
AC:
41
AN:
152284
Hom.:
0
Cov.:
32
AF XY:
0.000322
AC XY:
24
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.0000963
AC:
4
AN:
41544
American (AMR)
AF:
0.00163
AC:
25
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68030
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.518
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000143
Hom.:
0
Bravo
AF:
0.000121
ExAC
AF:
0.0000400
AC:
1

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
Sep 04, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Reported in an abstract in a patient diagnosed with DCM; however, the specific nucleotide substitution resulting in the G603R missense change was not provided and this individual also harbored additional cardiac variants, including a TTN nonsense variant (Gartner-Rommel et al. Clin Res Cardiol 107, Suppl 1, April 2018); Expression studies using myocardial cells from a patient with aggressive DCM showed aberrant splicing of RBM20 target genes (Gartner-Rommel et al. Clin Res Cardiol 107, Suppl 1, April 2018); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: Grtner-Rommel2018) -

not specified Benign:1
Jan 17, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: RBM20 c.1807G>A (p.Gly603Arg) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00017 in 156524 control chromosomes. The observed variant frequency is approximately 4 fold of the estimated maximal expected allele frequency for a pathogenic variant in RBM20 causing Dilated Cardiomyopathy phenotype (4.7e-05). c.1807G>A has been reported in the literature in individuals affected with Dilated Cardiomyopathy (Fomin_2021). These report(s) do not provide unequivocal conclusions about association of the variant with Dilated Cardiomyopathy. Co-occurrences with other pathogenic variant(s) have been reported (TTN c.71005A>T, p.Lys23559Ter; RBM20 c.2374dupG, p.Glu792GlyfsTer9), providing supporting evidence for a benign role. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 34731013). ClinVar contains an entry for this variant (Variation ID: 263763). Based on the evidence outlined above, the variant was classified as likely benign. -

Dilated cardiomyopathy 1DD Benign:1
Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Sep 17, 2020
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.98
BayesDel_addAF
Uncertain
0.050
T
BayesDel_noAF
Pathogenic
0.21
CADD
Pathogenic
30
DANN
Pathogenic
1.0
Eigen
Pathogenic
0.76
Eigen_PC
Pathogenic
0.81
FATHMM_MKL
Pathogenic
0.99
D
M_CAP
Pathogenic
0.41
D
MetaRNN
Uncertain
0.59
D
MetaSVM
Uncertain
0.74
D
PhyloP100
8.7
PrimateAI
Uncertain
0.78
T
PROVEAN
Uncertain
-4.2
D
REVEL
Pathogenic
0.65
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.0030
D
Vest4
0.74
MutPred
0.44
Gain of MoRF binding (P = 0.0607);
MVP
0.70
ClinPred
0.30
T
GERP RS
6.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
gMVP
0.81
Mutation Taster
=53/47
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs558674954; hg19: chr10-112570147; API